GlassScriptPhysician profile
Terence M Cooney
NPI 1316051584
$7,846.67
in general payments reported to CMS, 2019-2025
53 companies · $884 in 2025
The $884 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,416 · 2020: $137 · 2021: $677 · 2022: $1,493 · 2023: $1,632 · 2024: $1,608 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,104 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,103.87 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,124.31 | 2021-2025 | Qulipta, Ubrelvy, Viberzi |
| Pfizer INC. | $748.50 | 2019-2025 | |
| Lilly USA, LLC | $585.59 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $573.04 | 2019-2025 | Synjardy, Jardiance, Tradjenta |
| Novo Nordisk INC | $492.11 | 2019-2025 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $387.09 | 2022-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $383.77 | 2019-2025 | Breztri, Airsupra, Bevespi Aerosphere |
| Amgen INC. | $354.31 | 2019-2025 | Evenity, Prolia, Tavneos |
| Glaxosmithkline, LLC. | $300.98 | 2021-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $247.01 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $240.25 | 2019-2024 | |
| Gilead Sciences, INC. | $224.58 | 2019-2025 | |
| Amarin Pharma, INC. | $217.71 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $207.02 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $181.71 | 2023-2025 | Gemtesa |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $163.90 | 2019-2025 | Veozah |
| Teva Pharmaceuticals USA, INC. | $137.14 | 2023-2025 | Austedo Xr, Austedo Xr, Austedo |
| Boston Scientific Corporation | $137.10 | 2019-2025 | Watchman Flx, Watchman Access System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.70 | 2019-2024 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $106.90 | 2021-2023 | Eliquis |
| Janssen Pharmaceuticals, INC | $94.15 | 2019-2024 | Xarelto, Invega Sustenna |
| Daiichi Sankyo INC. | $77.34 | 2022-2024 | Injectafer |
| Baxter Healthcare | $54.59 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Abbott Laboratories | $46.68 | 2022-2025 | Freestyle Libre 3 |
| Insulet Corporation | $42.33 | 2019-2020 | |
| Kyowa Kirin, INC. | $40.11 | 2023-2024 | Crysvita |
| Xeris Pharmaceuticals, INC. | $33.48 | 2023 | Gvoke Hypopen |
| Dexcom, INC. | $33.00 | 2019-2025 | Dexcom G6 Transmitter |
| Ultragenyx Pharmaceutical INC. | $32.63 | 2022-2023 | |
| Ascensia Diabetes Care US INC. | $31.98 | 2024-2025 | |
| Lundbeck LLC | $28.46 | 2024-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $27.93 | 2021-2022 | |
| Allergan, INC. | $27.35 | 2019-2020 | |
| Pulmonx Corporation | $26.93 | 2023 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Neurelis, INC. | $25.82 | 2024 | Valtoco |
| Kowa Pharmaceuticals America, INC. | $25.34 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $22.47 | 2025 | Isturisa |
| Dynavax Technologies Corporation | $20.30 | 2025 | Heplisav-B |
| Sanofi Pasteur INC. | $18.70 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $18.35 | 2021 | |
| Seqirus USA INC | $16.88 | 2024 | Fluad, Flucelvax |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.60 | 2025 | Caplyta |
| Insmed, INC. | $16.29 | 2025 | Arikayce |
| Phathom Pharmaceuticals, INC. | $14.16 | 2025 | Voquezna |
| Esperion Therapeutics, INC. | $14.09 | 2021 | |
| Antares Pharma, INC. | $13.79 | 2019 | |
| Merck Sharp & Dohme LLC | $13.40 | 2024 | Vaxelis, Gardasil 9, Gardasil |
| Ardelyx, INC. | $13.39 | 2024 | Ibsrela |
| Nalpropion Pharmaceuticals LLC | $13.20 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.02 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.48 | 2021 | |
| Genentech USA, INC. | $11.03 | 2019 | |
| Organon LLC | $8.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terence Cooney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.